Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) Treatment of Recurrent/Metastatic (r/m) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 2 Study | OncLive
8:21
Petosemtamab (MCLA-158) With Pembrolizumab as First-line (1L) T…
Jun 16, 2024
onclive.com
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) Treatment of PD-L1 Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC): Phase 2 Trial | OncLive
Petosemtamab (MCLA-158) With Pembrolizumab as First-Line (1L) …
11 months ago
onclive.com
European Commission Approves KEYTRUDA® (Pembrolizumab) as Part of a Treatment Regimen for Adults with Resectable Locally Advanced Head and Neck Squamous Cell Carcinoma (LA-HNSCC) Expressing PD-L1 (CPS >1)
European Commission Approves KEYTRUDA® (Pembrolizumab) as …
6 months ago
marketscreener.com
🎙️ Episode 10 : Pembrolizumab Reshaping Head and Neck Cancer Treatment : KEYNOTE-689 | Dr. Pidugu
15:47
🎙️ Episode 10 : Pembrolizumab Reshaping Head and Neck Cance…
399 views10 months ago
YouTubeOncoTrial Insights with Dr.Pidugu
Pembrolizumab for head and neck cancer
6:17
Pembrolizumab for head and neck cancer
426 viewsJun 30, 2015
YouTubeecancer
Keynote 689#Perioperative Pembrolizumab#Immunotherapy#Cure#Head neck cancer
11:45
Keynote 689#Perioperative Pembrolizumab#Immunotherapy#…
504 viewsMay 9, 2025
YouTubeCancer education made simple # Chandrakant…
Let’s use Keytruda (pembrolizumab) as an example… it is an FDA-approved immunotherapy drug used to treat several cancers, including melanoma, lung, bladder, head and neck, breast, and colorectal cancers. Average cost: around $11,000–$13,000 per dose (given every 3–6 weeks) It’s a PD-1 checkpoint inhibitor that blocks the PD-1 receptor on immune cells, releasing the immune “brakes” so T-cells can attack cancer cells that hide from detection. 🤷🏼‍♀️Common side effects: fatigue, nausea, rash, join
Let’s use Keytruda (pembrolizumab) as an example… it is an FDA-appr…
1.7K views7 months ago
FacebookLaura Ramos
Makoto Tahara, ESMO 2022: 5-year results from KEYNOTE-048 - Pem…
20 viewsSep 14, 2022
touchoncology.com
1:46
Dr Yilmaz on HB-200 Arenavirus Plus Pembrolizumab in HPV16+ H…
151 viewsJun 24, 2024
YouTubeOncLive
Immunotherapy drug bolsters head and neck cancer treatment
Mar 1, 2022
uc.edu
1:43
Pembro Immunotherapy Treatment - a Game Changer for Head and Nec…
20 views1 month ago
YouTubeProfessor Christopher Nutting
1:36
Dr. Seiwert on Pembrolizumab in Head and Neck Cancer
222 viewsMay 29, 2015
YouTubeOncLive
1:16
Dr. Mehra on KEYNOTE-012 Results of Pembrolizumab in Head and Ne…
465 viewsJun 21, 2016
YouTubeOncLive
3:04
ASPEN-04: evorpacept with pembrolizumab & chemotherapy i…
10 views6 months ago
YouTubeVJOncology
2:08
ASPEN-03: evorpacept & pembrolizumab in unresectable, P…
26 views6 months ago
YouTubeVJOncology
Dr Weiss on Outcomes With Versamune HPV Plus Pembrolizu…
Oct 14, 2024
onclive.com
1:44
Significance of Pembrolizumab in Head and Neck Cancer
115 viewsJul 30, 2015
YouTubeTargeted Oncology
0:58
Dr. Machiels on Pembrolizumab in Head and Neck Cancer
147 viewsJun 22, 2017
YouTubeOncLive
Petosemtamab Plus Pembrolizumab vs. Pembrolizumab Alone for Firs…
Sep 27, 2024
onclive.com
1:05
Pembrolizumab KEYNOTE-689 Phase 3 Trial Update for LA-HNSC…
Apr 29, 2025
oncologytube.com
1:52
Dr. Burtness on Promise of Frontline Pembrolizumab in Metas…
179 viewsMar 29, 2019
YouTubeOncLive
0:40
Dr. Vokes on Selecting Nivolumab or Pembrolizumab for Head and N…
666 viewsDec 28, 2016
YouTubeOncLive
4:15
Keytruda Pembrolizumab Immunotherapy uses and side effe…
11.9K viewsOct 6, 2022
YouTubeTECHNO LEARNING
1:23
Dr. Burtness on the Benefit of Pembrolizumab in Head and Neck …
293 viewsNov 30, 2018
YouTubeOncLive
Immunotherapy drug approved for head and neck cancer - Cancer Re…
Oct 26, 2020
cancerresearchuk.org
7:06
Immunotherapy for HNSCC
255 viewsAug 31, 2017
YouTubeOncLive
5:10
Keynote 689 Pembrolizumab for Locally Advanced Disease 2025 H…
612 views11 months ago
YouTubeGlobal Resource for Advancing Cancer Education
2:09
Dr Perez on the Efficacy and Safety of Frontline Petosemtamab Plus P…
Aug 8, 2024
onclive.com
1:00
Dr. Papadimitrakopoulou Provides an Update on Pembrolizumab for …
564 viewsNov 7, 2014
YouTubeOncLive
Dr Siu on the Rationale for Combining Petosemtamab With P…
Oct 4, 2024
onclive.com
See more videos
Static thumbnail place holder